Home / Adalimumab / Czechia
CZ ATC L04AB04 · updated 2 Nov 2026
Adalimumab shortage in Czechia
Is there an Adalimumab shortage in Czechia?
Yes. As of 2 Nov 2026, 4 Adalimumab products are reported short in Czechia, the first since 19 Aug 2026. The company estimate for the return is 27 Nov 2026 (latest 22 Dec 2026). Main reason: manufacturing problem.
Also short in United States, Germany, Italy, Spain, Austria, Belgium, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | HYRIMOZ 20MG 20MG INJ SOL ISP 2(2X1)X0,2ML ISP | Sandoz GmbH, Kundl | 19 Aug 2026 | 27 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | HYRIMOZ 40MG 40MG INJ SOL PEP 2X0,4ML PEP | Sandoz GmbH, Kundl | 17 Sep 2026 | 27 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | HYRIMOZ 40MG 40MG INJ SOL ISP 2X0,4ML ISP | Sandoz GmbH, Kundl | 18 Sep 2026 | 27 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | HYRIMOZ 80MG 80MG INJ SOL PEP 1X0,8ML PEP | Sandoz GmbH, Kundl | 18 Sep 2026 | 22 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.